Femme et Homme
- | Pays :
- Russian Federation
- Macedonia, the former Yugoslav Republic of
- Italy
- Les 5 autres...
- | Organes : -
- | Spécialités : -
Extrait
This is a phase III multi-centre study in two periods: the first period is a phosphate binder and lipid lowering drugs washout for 8 weeks, the second period is a double-blind, randomised, parallel group, fixed dose, for 12 weeks.
Critère d'inclusion
- chronic kidney disease ,dialysis ,Hyperphosphatemia ,Dyslipidemia